Close

Novavax to Host Conference Call to Discuss Third Quarter 2017 Financial Results on November 7, 2017

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 4/26/2024

1. META
2. GOOGL
3. CMG
4. MSFT
5. LRCX
6. IBM
7. SPY
8. SNAP
9. INTC
10. HCP


October 31, 2017 4:05 PM EDT

GAITHERSBURG, Md., Oct. 31, 2017 (GLOBE NEWSWIRE) -- Novavax, Inc. (Nasdaq: NVAX) today announced it will report its third quarter financial and operating results following the close of U.S. financial markets on Tuesday, November 7, 2017.

Conference call details are as follows:

Date:Tuesday, November 7, 2017
Time:4:30 p.m. U.S. Eastern Time (ET)
Dial-in number:(877) 212-6076 (Domestic) or (707) 287-9331 (International)
Passcode:2479419
Webcast:www.novavax.com, “Investors”/ “Events”

Conference call and webcast replay:

Dates:Starts at 7:30 p.m. ET, Nov. 7, 2017 until 7:30 p.m. ET, Nov. 14, 2017
Dial-in number:(855) 859-2056 (Domestic) or (404) 537-3406 (International)
Passcode:2479419
Webcast:www.novavax.com, “Investors”/ “Events”, until February 7, 2018

About Novavax 

Novavax, Inc. (Nasdaq: NVAX) is a clinical-stage biotechnology company committed to delivering novel products to prevent a broad range of infectious diseases. Its recombinant nanoparticles and Matrix-M™ adjuvant technology are the foundation for groundbreaking innovation that improves global health through safe and effective vaccines.

Contact:         

Investor RelationsNovavax, Inc.Andrea N. Flynn, Ph.D.Director, Investor & Media Relations[email protected]240-268-2000               Westwicke PartnersJohn Woolford[email protected]443-213-0506

MediaRusso Partners, LLCDavid SchullMaggie Beller[email protected][email protected]212-845-4271

 

Source: Novavax, Inc.

Serious News for Serious Traders! Try StreetInsider.com Premium Free!

You May Also Be Interested In





Related Categories

Press Releases

Related Entities

Earnings